To recap, after a year of high-stakes negotiations, more than 70 per cent of Healthscope’s $1.6 billion lender syndicate has now signed a standstill agreement and given Brookfield and its advisers until mid-May to come up with rival offers to take on Di Pilla’s mooted bid, but the remaining 30 per cent have run out of patience and are selling out at a loss. |